COMBOGESIC® provides
fast, effective pain relief
from a wide range of pain

Acetaminophen acts mainly in the brain, while ibuprofen targets the production
of pain chemicals throughout the body and reduces inflammation.

Effectively reduces pain

Combogesic® provides 78% more effective pain relief than acetaminophen alone and 36% more effective than ibuprofen alone1,*.

Easy dosing regime

For the short-term management of mild to moderate acute pain and the reduction of fever, the recommended adult dose of Combogesic® is 1-2 tablets every 6 hours.

If pain or fever does not respond to 2 tablets, 3 tablets may be taken at subsequent doses, but only on the advice of a physician. Do not exceed 12 tablets over a 24-hour period.

Pediatrics
Pediatrics (< 18 years): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use.

Geriatrics
Geriatrics (> 65 years of age): Evidence from clinical studies and experience suggests that use in the geriatric population is associated with differences in safety or effectiveness and a brief discussion can be found in the appropriate sections of the product monograph found at: View Product Monograph here.

No adjustment in labelled dosage is necessary for older patients, who require acetaminophen therapy. Those who require therapy for longer than 3 days should consult their physician for condition monitoring; however, no reduction in recommended dosage is necessary. However, caution should be taken with regard to the use of ibuprofen as it should not be taken by adults over the age of 65 without consideration of co-morbidities and co-medications because of an increased risk of adverse effects, in particular heart failure, gastrointestinal ulceration and renal impairment.